Cargando…
Screening High-Risk Groups and the General Population for SARS-CoV-2 Nucleic Acids in a Mobile Biosafety Laboratory
The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has challenged public health systems worldwide. Therefore, large-scale testing capacity is extremely important diagnosis and exclusion diagnosis. However, fixed laboratories are limited or far away from remote areas. Fortunate...
Autores principales: | Guo, Zhimin, Li, Lin, Song, Yuanyuan, Xu, Jiancheng, Huang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414879/ https://www.ncbi.nlm.nih.gov/pubmed/34485233 http://dx.doi.org/10.3389/fpubh.2021.708476 |
Ejemplares similares
-
Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits
por: Zhu, Xuetong, et al.
Publicado: (2022) -
Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements
por: Pastorino, Boris, et al.
Publicado: (2017) -
Biosafety and Biosecurity: A Relative Risk-Based Framework for Safer, More Secure, and Sustainable Laboratory Capacity Building
por: Dickmann, Petra, et al.
Publicado: (2015) -
Perceived Effectiveness, Safety, and Attitudes Toward the Use of Nucleic Tests of SARS-CoV-2 Among Clinicians and General Public in China
por: Lan, Ruirui, et al.
Publicado: (2020) -
Biosafety Initiatives in BMENA Region: Identification of Gaps and Advances
por: Khan, Erum, et al.
Publicado: (2016)